[cite web | title = Entrez Gene: ELAC2 elaC homolog 2 (E. coli)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=60528| accessdate = ] ] PBB_Summary
section_title =
summary_text =
References
Further reading
PBB_Further_reading
citations =
*cite journal | author=Bonaldo MF, Lennon G, Soares MB |title=Normalization and subtraction: two approaches to facilitate gene discovery. |journal=Genome Res. |volume=6 |issue= 9 |pages= 791–806 |year= 1997 |pmid= 8889548 |doi=
*cite journal | author=Satijn DP, Gunster MJ, van der Vlag J, "et al." |title=RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor. |journal=Mol. Cell. Biol. |volume=17 |issue= 7 |pages= 4105–13 |year= 1997 |pmid= 9199346 |doi=
*cite journal | author=Sewalt RG, Gunster MJ, van der Vlag J, "et al." |title=C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. |journal=Mol. Cell. Biol. |volume=19 |issue= 1 |pages= 777–87 |year= 1999 |pmid= 9858600 |doi=
*cite journal | author=Rebbeck TR, Walker AH, Zeigler-Johnson C, "et al." |title=Association of HPC2/ELAC2 genotypes and prostate cancer. |journal=Am. J. Hum. Genet. |volume=67 |issue= 4 |pages= 1014–9 |year= 2000 |pmid= 10986046 |doi=
*cite journal | author=Tavtigian SV, Simard J, Teng DH, "et al." |title=A candidate prostate cancer susceptibility gene at chromosome 17p. |journal=Nat. Genet. |volume=27 |issue= 2 |pages= 172–80 |year= 2001 |pmid= 11175785 |doi= 10.1038/84808
*cite journal | author=Xu J, Zheng SL, Carpten JD, "et al." |title=Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. |journal=Am. J. Hum. Genet. |volume=68 |issue= 4 |pages= 901–11 |year= 2001 |pmid= 11254448 |doi=
*cite journal | author=Rökman A, Ikonen T, Mononen N, "et al." |title=ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. |journal=Cancer Res. |volume=61 |issue= 16 |pages= 6038–41 |year= 2001 |pmid= 11507049 |doi=
*cite journal | author=Wang L, McDonnell SK, Elkins DA, "et al." |title=Role of HPC2/ELAC2 in hereditary prostate cancer. |journal=Cancer Res. |volume=61 |issue= 17 |pages= 6494–9 |year= 2001 |pmid= 11522646 |doi=
*cite journal | author=Shea PR, Ferrell RE, Patrick AL, "et al." |title=ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago. |journal=Hum. Genet. |volume=111 |issue= 4-5 |pages= 398–400 |year= 2002 |pmid= 12384782 |doi= 10.1007/s00439-002-0816-1
*cite journal | author=Strausberg RL, Feingold EA, Grouse LH, "et al." |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899
*cite journal | author=Camp NJ, Tavtigian SV |title=Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. |journal=Am. J. Hum. Genet. |volume=71 |issue= 6 |pages= 1475–8 |year= 2003 |pmid= 12515253 |doi=
*cite journal | author=Fujiwara H, Emi M, Nagai H, "et al." |title=Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series. |journal=J. Hum. Genet. |volume=47 |issue= 12 |pages= 641–8 |year= 2003 |pmid= 12522685 |doi= 10.1007/s100380200099
*cite journal | author=Korver W, Guevara C, Chen Y, "et al." |title=The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex. |journal=Int. J. Cancer |volume=104 |issue= 3 |pages= 283–8 |year= 2003 |pmid= 12569551 |doi= 10.1002/ijc.10945
*cite journal | author=Shi Y, Sawada J, Sui G, "et al." |title=Coordinated histone modifications mediated by a CtBP co-repressor complex. |journal=Nature |volume=422 |issue= 6933 |pages= 735–8 |year= 2003 |pmid= 12700765 |doi= 10.1038/nature01550
*cite journal | author=Takaku H, Minagawa A, Takagi M, Nashimoto M |title=A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease. |journal=Nucleic Acids Res. |volume=31 |issue= 9 |pages= 2272–8 |year= 2003 |pmid= 12711671 |doi=
*cite journal | author=Severi G, Giles GG, Southey MC, "et al." |title=ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. |journal=J. Natl. Cancer Inst. |volume=95 |issue= 11 |pages= 818–24 |year= 2003 |pmid= 12783937 |doi=
*cite journal | author=Takahashi H, Lu W, Watanabe M, "et al." |title=Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men. |journal=Int. J. Cancer |volume=107 |issue= 2 |pages= 224–8 |year= 2003 |pmid= 12949798 |doi= 10.1002/ijc.11347
*cite journal | author=Stanford JL, Sabacan LP, Noonan EA, "et al." |title=Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. |journal=Cancer Epidemiol. Biomarkers Prev. |volume=12 |issue= 9 |pages= 876–81 |year= 2003 |pmid= 14504198 |doi=
*cite journal | author=Adler D, Kanji N, Trpkov K, "et al." |title=HPC2/ELAC2 gene variants associated with incident prostate cancer. |journal=J. Hum. Genet. |volume=48 |issue= 12 |pages= 634–8 |year= 2004 |pmid= 14625808 |doi= 10.1007/s10038-003-0091-6
*cite journal | author=Ota T, Suzuki Y, Nishikawa T, "et al." |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285
PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes
